Eur J Endocrinol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


DOI: 10.1530/eje.1.01852
European Journal of Endocrinology, Vol 152, Issue 2, 255-259
Copyright © 2005 by European Society of Endocrinology
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (3)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Richter-Unruh, A
Right arrow Articles by Wudy, S A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Richter-Unruh, A
Right arrow Articles by Wudy, S A

CLINICAL STUDY

Novel insertion frameshift mutation of the LH receptor gene: problematic clinical distinction of Leydig cell hypoplasia from enzyme defects primarily affecting testosterone biosynthesis

A Richter-Unruh, E Korsch1, O Hiort2, P M Holterhus2, A P Themmen3 and S A Wudy4

Department of Pediatric Hematology, Oncology and Endocrinology, University Children’s Hospital, Hufelandstr. 55, University of Essen, 45 122 Essen, Germany, 1 Department of Pediatrics, Children’s Hospital of Cologne, Germany, 2 Department of Pediatric Endocrinology, University Children’s Hospital, University of Schleswig-Holstein, Campus Lübeck, Germany, 3 Department of Internal Medicine, Erasmus MC, Rotterdam, The Netherlands and 4 Steroid Research Unit, Center of Child and Adolescent Medicine, Justus Liebig University, Giessen, Germany

(Correspondence should be addressed to A Richter-Unruh; Email: annette.richter-unruh{at}uni-essen.de)

Leydig cell hypoplasia (LCH) is a rare autosomal recessive condition that interferes with normal development of male external genitalia in 46,XY individuals and is caused by inactivating mutations of the LH receptor gene. The clinical and biochemical diagnostic parameters of LCH are not always specific and may therefore show significant overlap with other causes of insufficient testicular steroid biosynthesis. We have studied a 46,XY newborn with completely female external genitalia and palpable testes. Due to an increased basal serum ratio of androstenedione/testosterone, 17ß-hydroxysteroid dehydrogenase type 3 (17ß-HSD 3) deficiency was initially suspected. DNA analysis of the corresponding HSD17B3 gene, however, showed no abnormalities in the entire coding region. In contrast, direct sequencing of the LH receptor gene revealed a novel homozygous single nucleotide insertion in exon 11 (codon A589fs) producing a frame shift in the open reading frame predicting for premature termination of translation 17 amino acids downstream. From the genetic perspective, this mutation represents the first frame shift mutation in the LH receptor gene ever reported to date. From the clinical standpoint, LCH should always be considered in the differential diagnosis as steroid profiles may not be informative. Therefore, molecular genetic analysis should be warranted for androgen biosynthesis defects in all cases.




This article has been cited by other articles:


Home page
ReproductionHome page
A. P N Themmen
An update of the pathophysiology of human gonadotrophin subunit and receptor gene mutations and polymorphisms
Reproduction, September 1, 2005; 130(3): 263 - 274.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 European Society of Endocrinology.